141 related articles for article (PubMed ID: 27330661)
1. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
[TBL] [Abstract][Full Text] [Related]
2. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA.
Adamowicz P; Gieroń J
Clin Toxicol (Phila); 2016 Sep; 54(8):650-4. PubMed ID: 27227269
[TBL] [Abstract][Full Text] [Related]
3. An outbreak of exposure to a novel synthetic cannabinoid.
Monte AA; Bronstein AC; Cao DJ; Heard KJ; Hoppe JA; Hoyte CO; Iwanicki JL; Lavonas EJ
N Engl J Med; 2014 Jan; 370(4):389-90. PubMed ID: 24450915
[No Abstract] [Full Text] [Related]
4. Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer.
Nacca N; Schult R; Loflin R; Weltler A; Gorodetsky R; Kacinko S; Moran J; Krotulski A; Wiegand T
J Emerg Med; 2018 Dec; 55(6):788-791. PubMed ID: 30297193
[TBL] [Abstract][Full Text] [Related]
5. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
6. A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.
Schwartz MD; Trecki J; Edison LA; Steck AR; Arnold JK; Gerona RR
J Emerg Med; 2015 May; 48(5):573-80. PubMed ID: 25726258
[TBL] [Abstract][Full Text] [Related]
7. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.
Tyndall JA; Gerona R; De Portu G; Trecki J; Elie MC; Lucas J; Slish J; Rand K; Bazydlo L; Holder M; Ryan MF; Myers P; Iovine N; Plourde M; Weeks E; Hanley JR; Endres G; St Germaine D; Dobrowolski PJ; Schwartz M
Clin Toxicol (Phila); 2015; 53(10):950-6. PubMed ID: 26555732
[TBL] [Abstract][Full Text] [Related]
8. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
Dobaja M; Grenc D; Kozelj G; Brvar M
Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
[TBL] [Abstract][Full Text] [Related]
9. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
[TBL] [Abstract][Full Text] [Related]
10. AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema.
Maeda H; Kikura-Hanajiri R; Kawamura M; Nagashima E; Yoshida KI
Clin Toxicol (Phila); 2018 Feb; 56(2):143-145. PubMed ID: 28707493
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Synthetic Cannabinoid Deaths in State of Florida Prisoners.
Hvozdovich JA; Chronister CW; Logan BK; Goldberger BA
J Anal Toxicol; 2020 Apr; 44(3):298-300. PubMed ID: 31776572
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
13. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
[TBL] [Abstract][Full Text] [Related]
14. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids.
Sweeney B; Talebi S; Toro D; Gonzalez K; Menoscal JP; Shaw R; Hassen GW
Am J Emerg Med; 2016 Jan; 34(1):121.e1-2. PubMed ID: 26143311
[TBL] [Abstract][Full Text] [Related]
16. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
[TBL] [Abstract][Full Text] [Related]
17. Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Abouchedid R; Ho JH; Hudson S; Dines A; Archer JR; Wood DM; Dargan PI
J Med Toxicol; 2016 Dec; 12(4):396-401. PubMed ID: 27456262
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review.
Armstrong F; McCurdy MT; Heavner MS
Pharmacotherapy; 2019 Apr; 39(4):508-513. PubMed ID: 30811628
[TBL] [Abstract][Full Text] [Related]
19. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
[TBL] [Abstract][Full Text] [Related]
20. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
